Related Experiment Video

Updated: May 26, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Effects of vaccine on rotavirus disease in the pediatric population

Penelope H Dennehy1

  • 1Division of Pediatric Infectious Diseases, Department of Pediatrics, Hasbro Children's Hospital, The Alpert Medical School of Brown University, Providence, Rhode Island, USA. pdennehy@lifespan.org

Current Opinion in Pediatrics
|December 23, 2011
PubMed

Insights

Two effective rotavirus vaccines significantly reduce severe diarrhea and hospitalizations in infants globally. Widespread vaccination has led to dramatic drops in rotavirus disease, demonstrating substantial public health benefits.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Rotavirus infection is a leading cause of severe diarrhea in infants worldwide.
  • It significantly contributes to childhood morbidity and mortality globally.
  • Two effective rotavirus vaccines are available for infant immunization.

Purpose of the Study:

  • To review studies assessing the impact of rotavirus vaccination on rotavirus disease in children.
  • To summarize the effects of rotavirus vaccines on public health outcomes.
  • To evaluate vaccine effectiveness and safety in diverse settings.

Main Methods:

  • Systematic review of studies on rotavirus vaccine impact.
  • Analysis of health outcomes, including hospitalizations and emergency visits.
  • Assessment of indirect benefits like herd immunity.
  • Monitoring of rotavirus strain changes post-vaccination.

Main Results:

  • Rotavirus vaccination dramatically reduced severe rotavirus-related hospitalizations and emergency visits in industrialized nations.
  • Clinical trials in developing countries showed significant reductions in severe rotavirus diarrhea.
  • Herd immunity was observed in several countries following routine immunization.
  • No significant rotavirus strain shifts or escape mutants were identified.

Conclusions:

  • Two well-tolerated and effective rotavirus vaccines have substantially reduced the burden of rotavirus gastroenteritis.
  • Vaccination programs have proven beneficial in both developed and developing countries.
  • Rotavirus vaccines are critical tools for improving child health globally.
Abstract

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...